These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Cytokine therapy for metastatic renal cell carcinoma]. Eto M; Naito S Gan To Kagaku Ryoho; 2002 Oct; 29(10):1738-44. PubMed ID: 12402423 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma. Donskov F Dan Med Bull; 2007 Nov; 54(4):249-65. PubMed ID: 18208677 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of prostatic, corpus uteri and kidney neoplasms (hypernephromas) in general practice]. Obrecht JP; Mayr AC; Nagel G Schweiz Med Wochenschr; 1973 Oct; 103(41):1414-21. PubMed ID: 4751562 [No Abstract] [Full Text] [Related]
27. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm. Shaheen PE; Bukowski RM Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470 [TBL] [Abstract][Full Text] [Related]
28. Chemosensitivity of murine renal carcinoma. de Vere White R; Ki Hong W; Tannenbaum M; Olsson CA Urol Res; 1982 Feb; 10(1):27-30. PubMed ID: 7200273 [TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Köpf-Maier P Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588 [TBL] [Abstract][Full Text] [Related]
30. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma]. Ausch C; Rosen HR; Schiessel R Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxic chemotherapy for advanced renal cell carcinoma. Yagoda A; Petrylak D; Thompson S Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752 [TBL] [Abstract][Full Text] [Related]
35. Pediatric renal adenocarcinoma: a review of our series. Bosquet M; Domínguez C; Balaguer J; Serrano A; Estornell F; Martínez-Verduch M; García-Ibarra F Urology; 2008 Oct; 72(4):790-3. PubMed ID: 18502480 [TBL] [Abstract][Full Text] [Related]
36. Renal medullary carcinoma: case report and review of the literature. Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature. Weiselberg L; Budman D; Vinciguerra V; Schulman P; Degnan TJ Cancer Clin Trials; 1981; 4(2):195-8. PubMed ID: 7249256 [TBL] [Abstract][Full Text] [Related]
38. New drug therapies for advanced renal cell carcinoma. Gore ME; Harrison ML; Montes A Expert Rev Anticancer Ther; 2007 Jan; 7(1):57-71. PubMed ID: 17187520 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model. Williams PD; Kantor P; Murphy GP Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884 [TBL] [Abstract][Full Text] [Related]
40. [Our experience with renal adenocarcinoma (II): clinical course, diagnosis, and prognostic factors before surgical treatment]. Rivas del Fresno M; Fernández Gómez JM; San Martín Blanco A; Sahagún Argüello JL; Martín Benito JL; Alonso Sainz F Arch Esp Urol; 1995; 48(1):67-71. PubMed ID: 7733690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]